Mittendorf EA - Search Results

1

Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy.

Weiss A, King C, Vincuilla J, Parker T, Portnow L, Nakhlis F, Dominici L, Mittendorf EA, King TA. Weiss A, et al. Among authors: mittendorf ea. Breast Cancer Res Treat. 2022 Sep;195(2):181-189. doi: 10.1007/s10549-022-06677-2. Epub 2022 Jul 28. Breast Cancer Res Treat. 2022. PMID: 35900704

2

Staging of breast cancer in the neoadjuvant setting.

Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Jeruss JS, et al. Among authors: mittendorf ea. Cancer Res. 2008 Aug 15;68(16):6477-81. doi: 10.1158/0008-5472.CAN-07-6520. Cancer Res. 2008. PMID: 18701468 Free PMC article. Review.

3

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.

Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F. Hunt KK, et al. Among authors: mittendorf ea. Ann Surg. 2009 Oct;250(4):558-66. doi: 10.1097/SLA.0b013e3181b8fd5e. Ann Surg. 2009. PMID: 19730235

4

Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma.

Silberfein EJ, Hunt KK, Broglio K, Shen J, Sahin A, Le-Petross H, Oh J, Litton J, Hwang RF, Mittendorf EA. Silberfein EJ, et al. Among authors: mittendorf ea. Clin Breast Cancer. 2010 Feb;10(1):52-8. doi: 10.3816/CBC.2010.n.007. Clin Breast Cancer. 2010. PMID: 20133259

5

A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.

Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. Bedrosian I, et al. Among authors: mittendorf ea. Cancer. 2010 Jun 1;116(11):2543-8. doi: 10.1002/cncr.25096. Cancer. 2010. PMID: 20336790 Free PMC article. Clinical Trial.

6

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.

Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, Babiera GV, Meric-Bernstam F, Hunt KK, Kuerer HM. Dominici LS, et al. Among authors: mittendorf ea. Cancer. 2010 Jun 15;116(12):2884-9. doi: 10.1002/cncr.25152. Cancer. 2010. PMID: 20564395 Free PMC article.

7

Sentinel lymph node dissection is technically feasible in older breast cancer patients.

Valero V 3rd, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA. Valero V 3rd, et al. Among authors: mittendorf ea. Clin Breast Cancer. 2010 Dec 1;10(6):477-82. doi: 10.3816/CBC.2010.n.063. Clin Breast Cancer. 2010. PMID: 21147692

8

Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.

Wu Y, Mittendorf EA, Kelten C, Tucker SL, Wei W, Middleton LP, Broglio K, Buchholz TA, Hunt KK, Sahin AA. Wu Y, et al. Among authors: mittendorf ea. Cancer. 2012 Mar 15;118(6):1507-14. doi: 10.1002/cncr.26458. Epub 2011 Aug 25. Cancer. 2012. PMID: 22009292 Free article.

9

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.

Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Kuerer HM, et al. Among authors: mittendorf ea. Breast Cancer Res Treat. 2012 Jun;133(3):1131-41. doi: 10.1007/s10549-012-1999-3. Epub 2012 Mar 4. Breast Cancer Res Treat. 2012. PMID: 22392043 Free PMC article.

10

Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.

Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Dominici LS, et al. Among authors: mittendorf ea. Breast Cancer Res. 2012 May 23;14(3):R82. doi: 10.1186/bcr3197. Breast Cancer Res. 2012. PMID: 22621306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

367 results

Search Page